James C. Momtazee

CIK: 0001209181

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)14 (58.3%)

Compensation grants

Other (G, F, J, C, D, …)10 (41.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ROIV

Roivant Sciences Ltd.

Director

BBIO

BridgeBio Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (24 total)

ROIV
Roivant Sciences Ltd.
Oct 23, 2026
Award(A)
Direct
383 shares-
ROIV
Roivant Sciences Ltd.
Oct 23, 2026
Tax Payment(F)
Direct
77 shares at avg. $36.49$3K
ROIV
Roivant Sciences Ltd.
Sep 16, 2026
Award(A)
Direct
5.1K shares-
ROIV
Roivant Sciences Ltd.
Sep 10, 2026
Tax Payment(F)
Direct
2.9K shares at avg. $40.94$119K
ROIV
Roivant Sciences Ltd.
Jul 17, 2026
Award(A)
Direct
405 shares-
BBIO
BridgeBio Pharma, Inc.
Jun 22, 2026
Award(A)
Direct
4K shares-
ROIV
Roivant Sciences Ltd.
Apr 17, 2026
Tax Payment(F)
Direct
94 shares at avg. $29.83$3K
ROIV
Roivant Sciences Ltd.
Apr 17, 2026
Award(A)
Direct
469 shares-
ROIV
Roivant Sciences Ltd.
Jan 20, 2026
Tax Payment(F)
Direct
122 shares at avg. $22.98$3K
ROIV
Roivant Sciences Ltd.
Jan 20, 2026
Award(A)
Direct
609 shares-
ROIV
Roivant Sciences Ltd.
Oct 20, 2025
Award(A)
Direct
789 shares-
ROIV
Roivant Sciences Ltd.
Oct 20, 2025
Tax Payment(F)
Direct
158 shares at avg. $17.74$3K
ROIV
Roivant Sciences Ltd.
Sep 10, 2025
Other(J)
Direct
3.3K shares at avg. $13.77$45K
ROIV
Roivant Sciences Ltd.
Sep 10, 2025
Award(A)
Direct
14.5K shares-
ROIV
Roivant Sciences Ltd.
Jul 17, 2025
Award(A)
Direct
1.2K shares-
ROIV
Roivant Sciences Ltd.
Jul 17, 2025
Tax Payment(F)
Direct
241 shares at avg. $11.65$3K
BBIO
BridgeBio Pharma, Inc.
Jun 20, 2025
Award(A)
Direct
6.6K shares-
ROIV
Roivant Sciences Ltd.
Apr 17, 2025
Tax Payment(F)
Direct
276 shares at avg. $10.15$3K
ROIV
Roivant Sciences Ltd.
Apr 17, 2025
Award(A)
Direct
1.4K shares-
ROIV
Roivant Sciences Ltd.
Jan 23, 2025
Tax Payment(F)
Direct
306 shares at avg. $11.21$3K
ROIV
Roivant Sciences Ltd.
Jan 23, 2025
Award(A)
Direct
1.2K shares-
ROIV
Roivant Sciences Ltd.
Oct 21, 2024
Award(A)
Direct
1.2K shares-
ROIV
Roivant Sciences Ltd.
Sep 12, 2024
Other(J)
Direct
3.1K shares at avg. $12.12$37K
ROIV
Roivant Sciences Ltd.
Sep 10, 2024
Award(A)
Direct
16.4K shares-

		Type	Shares	Price		Ownership
Oct 23, 2026	ROIV Roivant Sciences Ltd.	Award(A)	383	-	$0	Direct
Oct 23, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	77	$36.49	$2,810	Direct
Sep 16, 2026	ROIV Roivant Sciences Ltd.	Award(A)	5,054	-	$0	Direct
Sep 10, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	2,905	$40.94	$118,931	Direct
Jul 17, 2026	ROIV Roivant Sciences Ltd.	Award(A)	405	-	$0	Direct
Jun 22, 2026	BBIO BridgeBio Pharma, Inc.	Award(A)	3,990	-	$0	Direct
Apr 17, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	94	$29.83	$2,804	Direct
Apr 17, 2026	ROIV Roivant Sciences Ltd.	Award(A)	469	-	$0	Direct
Jan 20, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	122	$22.98	$2,804	Direct
Jan 20, 2026	ROIV Roivant Sciences Ltd.	Award(A)	609	-	$0	Direct
Oct 20, 2025	ROIV Roivant Sciences Ltd.	Award(A)	789	-	-	Direct
Oct 20, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	158	$17.74	$2,803	Direct
Sep 10, 2025	ROIV Roivant Sciences Ltd.	Other(J)	3,282	$13.77	$45,193	Direct
Sep 10, 2025	ROIV Roivant Sciences Ltd.	Award(A)	14,524	-	-	Direct
Jul 17, 2025	ROIV Roivant Sciences Ltd.	Award(A)	1,201	-	-	Direct
Jul 17, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	241	$11.65	$2,808	Direct
Jun 20, 2025	BBIO BridgeBio Pharma, Inc.	Award(A)	6,589	-	-	Direct
Apr 17, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	276	$10.15	$2,801	Direct
Apr 17, 2025	ROIV Roivant Sciences Ltd.	Award(A)	1,379	-	-	Direct
Jan 23, 2025	ROIV Roivant Sciences Ltd.	Tax Payment(F)	306	$11.21	$3,430	Direct
Jan 23, 2025	ROIV Roivant Sciences Ltd.	Award(A)	1,248	-	$0	Direct
Oct 21, 2024	ROIV Roivant Sciences Ltd.	Award(A)	1,231	-	$0	Direct
Sep 12, 2024	ROIV Roivant Sciences Ltd.	Other(J)	3,056	$12.12	$37,039	Direct
Sep 10, 2024	ROIV Roivant Sciences Ltd.	Award(A)	16,406	-	$0	Direct

1-24 of 24 transactions

About MOMTAZEE JAMES C

MOMTAZEE JAMES C (SEC CIK 0001209181) files insider reports with the SEC as Director of Roivant Sciences Ltd. (ROIV) and Director of BridgeBio Pharma, Inc. (BBIO).

Signal8 holds 16 ownership filings by MOMTAZEE JAMES C, all Form 4s, filed between Sep 12, 2024 and Oct 27, 2026. Those filings report 24 transactions, from Sep 10, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MOMTAZEE JAMES C's filings is in LONDON.

Recent filings by MOMTAZEE JAMES C

Oct 23, 2026: Grant or award of ROIV shares (Form 4, code A).
Oct 23, 2026: Tax withholding of ROIV shares (Form 4, code F).
Sep 16, 2026: Grant or award of ROIV shares (Form 4, code A).
Sep 10, 2026: Tax withholding of ROIV shares (Form 4, code F).
Jul 17, 2026: Grant or award of ROIV shares (Form 4, code A).

Other insiders filing for Roivant Sciences Ltd. (ROIV)

Venker Eric, President & Immunovant CEO
Oren Ilan, Director
Epperly Melissa B,, Director
Sukhatme Mayukh, President & CIO
Gline Matthew, CEO
Torti Frank, President and Vant Chair

How to read Form 4 transaction codes